The increased HER3 is phosphorylated by HER2, while the reduction in the phosphatase activity of HER3 hinders dephosphorylation, thereby maintaining the PI3K/AKT pathway’s activity [96] and compensating for tumor growth signaling. Here, ERBB2 is linked to neoplasm.